Idun Pharmaceuticals, Inc.
Records under this name other than patents Idun Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Idun Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,692,038 | Crystalline Forms Formerly held In force · High confidence | In force | High confidence | |
| US 6,790,989 | Inhibitors of the ICE/ced-3 family of cysteine proteases Formerly held Term ended Ended no later than Jan 26, 2021 · From the USPTO record | Term ended | Ended no later than Jan 26, 2021 | From the USPTO record |
| US 6,762,045 | Membrane derived caspase-3, compositions comprising the same and methods of use therefor Formerly held Term ended Term ended Nov 20, 2020 · From the USPTO record | Term ended | Term ended Nov 20, 2020 | From the USPTO record |
| US 7,053,056 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Formerly held Term ended Term ended Apr 8, 2020 · From the USPTO record | Term ended | Term ended Apr 8, 2020 | From the USPTO record |
| US 6,287,795 | Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of use Term ended Term ended Apr 13, 2019 · From the USPTO record | Term ended | Term ended Apr 13, 2019 | From the USPTO record |
| US 7,183,260 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Formerly held Term ended Term ended Oct 23, 2018 · From the USPTO record | Term ended | Term ended Oct 23, 2018 | From the USPTO record |
| US 6,197,750 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Formerly held Term ended Term ended Oct 22, 2018 · From the USPTO record | Term ended | Term ended Oct 22, 2018 | From the USPTO record |
| US 6,544,951 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases Formerly held Term ended Ended no later than Oct 22, 2018 · From the USPTO record | Term ended | Ended no later than Oct 22, 2018 | From the USPTO record |
| US 6,824,991 | Human bad polypeptides, encoding nucleic acids and methods of use Formerly held Term ended Term ended Jun 2, 2018 · From the USPTO record | Term ended | Term ended Jun 2, 2018 | From the USPTO record |
| US 6,693,096 | Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors Formerly held Term ended Term ended Nov 29, 2017 · From the USPTO record | Term ended | Term ended Nov 29, 2017 | From the USPTO record |